INTRODUCTION: This review focuses on the process of arteriosclerosis arising from oxidative stress on lipoproteins and the general failure of randomized human trials using vitamins to retard this process. REVIEW: As well as clinical trials, the paper reviews the mechanisms by which a variety of oxidants act. Antioxidants are discussed, emphasizing interactions of vitamins C and E with transition metals that can lead to prooxidation. There is a focus on interactions between supplemental or co-antioxidants that counterbalance prooxidant effects of one another. CONCLUSIONS: It is concluded that normal cellular supplementation mechanisms are poorly accessible in the arteriosclerotic plaque leading to a prooxidant environment in which the haphazard introduction of vitamins could potentially be hazardous. Continued investigations into basic and clinical redox interactions of the kind discussed in this review using new measuring techniques may lead to approaches whereby antioxidants can be introduced into tissue in controlled ways for reducing arteriosclerosis.
INTRODUCTION: This review focuses on the process of arteriosclerosis arising from oxidative stress on lipoproteins and the general failure of randomized human trials using vitamins to retard this process. REVIEW: As well as clinical trials, the paper reviews the mechanisms by which a variety of oxidants act. Antioxidants are discussed, emphasizing interactions of vitamins C and E with transition metals that can lead to prooxidation. There is a focus on interactions between supplemental or co-antioxidants that counterbalance prooxidant effects of one another. CONCLUSIONS: It is concluded that normal cellular supplementation mechanisms are poorly accessible in the arteriosclerotic plaque leading to a prooxidant environment in which the haphazard introduction of vitamins could potentially be hazardous. Continued investigations into basic and clinical redox interactions of the kind discussed in this review using new measuring techniques may lead to approaches whereby antioxidants can be introduced into tissue in controlled ways for reducing arteriosclerosis.
Authors: Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Elizabeth Head; Daniel L Gillen Journal: Am J Med Genet A Date: 2011-07-07 Impact factor: 2.802
Authors: Clara A Veloso; Bárbara F Oliveira; Fernanda Elisa P Mariani; Fernanda S Fagundes-Neto; Caroline Maria O Volpe; José Augusto Nogueira-Machado; Míriam M Chaves Journal: Redox Rep Date: 2013 Impact factor: 4.412
Authors: Alberto Ascherio; Peter A LeWitt; Kui Xu; Shirley Eberly; Arthur Watts; Wayne R Matson; Connie Marras; Karl Kieburtz; Alice Rudolph; Mikhail B Bogdanov; Steven R Schwid; Marsha Tennis; Caroline M Tanner; M Flint Beal; Anthony E Lang; David Oakes; Stanley Fahn; Ira Shoulson; Michael A Schwarzschild Journal: Arch Neurol Date: 2009-12
Authors: Gøran Paulsen; Kristoffer T Cumming; Geir Holden; Jostein Hallén; Bent Ronny Rønnestad; Ole Sveen; Arne Skaug; Ingvild Paur; Nasser E Bastani; Hege Nymo Østgaard; Charlotte Buer; Magnus Midttun; Fredrik Freuchen; Havard Wiig; Elisabeth Tallaksen Ulseth; Ina Garthe; Rune Blomhoff; Haakon B Benestad; Truls Raastad Journal: J Physiol Date: 2014-02-03 Impact factor: 5.182
Authors: Heather K Vincent; Cheryl M Bourguignon; Arthur L Weltman; Kevin R Vincent; Eugene Barrett; Karen E Innes; Ann G Taylor Journal: Metabolism Date: 2009-02 Impact factor: 8.694